Literature DB >> 27435091

Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline.

Katia Hardies, Yiying Cai, Claude Jardel, Anna C Jansen, Mian Cao, Patrick May, Tania Djémié, Caroline Hachon Le Camus, Kathelijn Keymolen, Tine Deconinck, Vikas Bhambhani, Catherine Long, Samin A Sajan, Katherine L Helbig, Arvid Suls, Rudi Balling, Ingo Helbig, Peter De Jonghe, Christel Depienne, Pietro De Camilli, Sarah Weckhuysen.   

Abstract

SYNJ1 encodes a polyphosphoinositide phosphatase, synaptojanin 1, which contains two consecutive phosphatase domains and plays a prominent role in synaptic vesicle dynamics. Autosomal recessive inherited variants in SYNJ1 have previously been associated with two different neurological diseases: a recurrent homozygous missense variant (p.Arg258Gln) that abolishes Sac1 phosphatase activity was identified in three independent families with early onset parkinsonism, whereas a homozygous nonsense variant (p.Arg136*) causing a severe decrease of mRNA transcript was found in a single patient with intractable epilepsy and tau pathology. We performed whole exome or genome sequencing in three independent sib pairs with early onset refractory seizures and progressive neurological decline, and identified novel segregating recessive SYNJ1 defects. A homozygous missense variant resulting in an amino acid substitution (p.Tyr888Cys) was found to impair, but not abolish, the dual phosphatase activity of SYNJ1, whereas three premature stop variants (homozygote p.Trp843* and compound heterozygote p.Gln647Argfs*6/p.Ser1122Thrfs*3) almost completely abolished mRNA transcript production. A genetic follow-up screening in a large cohort of 543 patients with a wide phenotypical range of epilepsies and intellectual disability revealed no additional pathogenic variants, showing that SYNJ1 deficiency is rare and probably linked to a specific phenotype. While variants leading to early onset parkinsonism selectively abolish Sac1 function, our results provide evidence that a critical reduction of the dual phosphatase activity of SYNJ1 underlies a severe disorder with neonatal refractory epilepsy and a neurodegenerative disease course. These findings further expand the clinical spectrum of synaptic dysregulation in patients with severe epilepsy, and emphasize the importance of this biological pathway in seizure pathophysiology.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  SYNJ1; SYNJ1 dual phosphatase activity; early onset epilepsy; neurodegenerative disorder; recessive disorder

Mesh:

Substances:

Year:  2016        PMID: 27435091      PMCID: PMC4995362          DOI: 10.1093/brain/aww180

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  51 in total

1.  The SH3 domains of endophilin and amphiphysin bind to the proline-rich region of synaptojanin 1 at distinct sites that display an unconventional binding specificity.

Authors:  G Cestra; L Castagnoli; L Dente; O Minenkova; A Petrelli; N Migone; U Hoffmüller; J Schneider-Mergener; G Cesareni
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

2.  The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures.

Authors:  Catharine E Krebs; Siamak Karkheiran; James C Powell; Mian Cao; Vladimir Makarov; Hossein Darvish; Gilbert Di Paolo; Ruth H Walker; Gholam Ali Shahidi; Joseph D Buxbaum; Pietro De Camilli; Zhenyu Yue; Coro Paisán-Ruiz
Journal:  Hum Mutat       Date:  2013-07-19       Impact factor: 4.878

3.  The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals.

Authors:  Meera Mani; Sang Yoon Lee; Louise Lucast; Ottavio Cremona; Gilbert Di Paolo; Pietro De Camilli; Timothy A Ryan
Journal:  Neuron       Date:  2007-12-20       Impact factor: 17.173

Review 4.  Mutations in phosphoinositide metabolizing enzymes and human disease.

Authors:  Heather J McCrea; Pietro De Camilli
Journal:  Physiology (Bethesda)       Date:  2009-02

5.  Synaptojanin 1 contributes to maintaining the stability of GABAergic transmission in primary cultures of cortical neurons.

Authors:  A Luthi; G Di Paolo; O Cremona; L Daniell; P De Camilli; D A McCormick
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

6.  Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift.

Authors:  Pablo Cingolani; Viral M Patel; Melissa Coon; Tung Nguyen; Susan J Land; Douglas M Ruden; Xiangyi Lu
Journal:  Front Genet       Date:  2012-03-15       Impact factor: 4.599

7.  Zebrafish Cacna1fa is required for cone photoreceptor function and synaptic ribbon formation.

Authors:  Sujuan Jia; Akira Muto; Wilda Orisme; Hannah E Henson; Chaithanyarani Parupalli; Bensheng Ju; Herwig Baier; Michael R Taylor
Journal:  Hum Mol Genet       Date:  2014-01-12       Impact factor: 5.121

8.  Generation of high curvature membranes mediated by direct endophilin bilayer interactions.

Authors:  K Farsad; N Ringstad; K Takei; S R Floyd; K Rose; P De Camilli
Journal:  J Cell Biol       Date:  2001-10-15       Impact factor: 10.539

9.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

10.  Synaptojanin cooperates in vivo with endophilin through an unexpected mechanism.

Authors:  Yongming Dong; Yueyang Gou; Yi Li; Yan Liu; Jihong Bai
Journal:  Elife       Date:  2015-04-28       Impact factor: 8.140

View more
  25 in total

1.  A Clinical and Molecular Genetic Study of 50 Families with Autosomal Recessive Parkinsonism Revealed Known and Novel Gene Mutations.

Authors:  Shaghayegh Taghavi; Rita Chaouni; Abbas Tafakhori; Luis J Azcona; Saghar Ghasemi Firouzabadi; Mir Davood Omrani; Javad Jamshidi; Babak Emamalizadeh; Gholam Ali Shahidi; Mona Ahmadi; Seyed Amir Hassan Habibi; Azadeh Ahmadifard; Atena Fazeli; Marzieh Motallebi; Peyman Petramfar; Saeed Askarpour; Shiva Askarpour; Hossein Ali Shahmohammadibeni; Neda Shahmohammadibeni; Hajar Eftekhari; Amir Ehtesham Shafiei Zarneh; Saeed Mohammadihosseinabad; Mehdi Khorrami; Safa Najmi; Ahmad Chitsaz; Parasto Shokraeian; Hossein Ehsanbakhsh; Jalal Rezaeidian; Reza Ebrahimi Rad; Faranak Madadi; Monavvar Andarva; Elham Alehabib; Minoo Atakhorrami; Seyed Erfan Mortazavi; Zahra Azimzadeh; Mahdis Bayat; Amir Mohammad Besharati; Mohammad Ali Harati-Ghavi; Samareh Omidvari; Zahra Dehghani-Tafti; Faraz Mohammadi; Banafsheh Mohammad Hossein Pour; Hamid Noorollahi Moghaddam; Ehsan Esmaili Shandiz; Arman Habibi; Zahra Taherian-Esfahani; Hossein Darvish; Coro Paisán-Ruiz
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

Review 2.  Coatopathies: Genetic Disorders of Protein Coats.

Authors:  Esteban C Dell'Angelica; Juan S Bonifacino
Journal:  Annu Rev Cell Dev Biol       Date:  2019-08-09       Impact factor: 13.827

3.  [Chronic phosphoproteomic in temporal lobe epilepsy mouse models induced by kainic acid].

Authors:  Z M Sun; Q Chen; M H Li; W N Ma; X Y Zhao; Z Huang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-04-18

4.  Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons.

Authors:  Mian Cao; Yumei Wu; Ghazaleh Ashrafi; Amber J McCartney; Heather Wheeler; Eric A Bushong; Daniela Boassa; Mark H Ellisman; Timothy A Ryan; Pietro De Camilli
Journal:  Neuron       Date:  2017-02-22       Impact factor: 17.173

5.  A Novel SYNJ1 Mutation in a Tunisian Family with Juvenile Parkinson's Disease Associated with Epilepsy.

Authors:  Sawssan Ben Romdhan; Salma Sakka; Nouha Farhat; Siwar Triki; Mariem Dammak; Chokri Mhiri
Journal:  J Mol Neurosci       Date:  2018-09-05       Impact factor: 3.444

Review 6.  New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.

Authors:  Andreas Puschmann
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

Review 7.  NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment.

Authors:  Ana Fernandez-Marmiesse; Sofia Gouveia; Maria L Couce
Journal:  Curr Med Chem       Date:  2018-01-30       Impact factor: 4.530

Review 8.  Synapses in neurodegenerative diseases.

Authors:  Jae Ryul Bae; Sung Hyun Kim
Journal:  BMB Rep       Date:  2017-05       Impact factor: 4.778

9.  SYNJ1 gene associated with neonatal onset of neurodegenerative disorder and intractable seizure.

Authors:  Nuha Al Zaabi; Noora Al Menhali; Fatma Al-Jasmi
Journal:  Mol Genet Genomic Med       Date:  2017-11-27       Impact factor: 2.183

10.  First-line exome sequencing in Palestinian and Israeli Arabs with neurological disorders is efficient and facilitates disease gene discovery.

Authors:  Holger Hengel; Rebecca Buchert; Marc Sturm; Tobias B Haack; Yvonne Schelling; Muhammad Mahajnah; Rajech Sharkia; Abdussalam Azem; Ghassan Balousha; Zaid Ghanem; Mohammed Falana; Osama Balousha; Suhail Ayesh; Reinhard Keimer; Werner Deigendesch; Jimmy Zaidan; Hiyam Marzouqa; Peter Bauer; Ludger Schöls
Journal:  Eur J Hum Genet       Date:  2020-03-25       Impact factor: 5.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.